Apollomics vs OSE Immunotherapeutics

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies

26 employees · est. 2015 · Foster City, United States

OSE Immunotherapeutics

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients

76 employees · est. 2012 · Nantes, France

OSE Immunotherapeutics is the older company (2015 vs 2012); OSE Immunotherapeutics is the larger of the two.

Side-by-Side Comparison

Metric	Apollomics	OSE Immunotherapeutics
Founded
Founded	2015	2012 older
Headquarters
Headquarters	Foster City, United States	Nantes, France
Employees
Employees	26	76 larger
Industry
Industry	Biotechnology, Health Care, Pharmaceutical	Biotechnology, Medical Devices, Pharmaceutical
Funding Stage
Funding Stage	Post-IPO Equity	Grant
Total Funding
Total Funding	$262.60M	$53.95M
Funding Rounds
Funding Rounds	5	7
Taxonomy
Taxonomy	Biopharmaceutical CompanyOncology TherapiesCombination TherapiesCancer TreatmentDrug DevelopmentImmune System +8	Biotech CompanyImmunotherapyCancerInflammatory DiseasesDrug DiscoveryBiCKI Platform +9
Website
Website	apollomicsinc.com	ose-immuno.com

About Apollomics

Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in both the U.S. and China, aiming to harness synergies by collaborating with biotechnology companies in...

View Full Profile Alternatives

About OSE Immunotherapeutics

OSE Immunotherapeutics is an integrated biotech company founded in 2012, headquartered in France. The company focuses on developing first-in-class assets targeting cancer and inflammatory diseases. Its well-balanced first-in-class clinical pipeline includes promising products such as Tedopi® for non...

View Full Profile Alternatives

Also comparing in this category

Comparing more than these two?

Get Apollomics, OSE Immunotherapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Apollomics compare?

A PDF of Apollomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Book a 7-day Readout How the Readout works

Frequently Asked Questions

Apollomics was founded in 2015, based in Foster City, United States, with 26 employees. Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in bo. OSE Immunotherapeutics was founded in 2012, based in Nantes, France, with 76 employees. OSE Immunotherapeutics is an integrated biotech company founded in 2012, headquartered in France. The company focuses on developing first-in-class assets targeting cancer and inflammatory diseases. It.

Apollomics has raised $262.60M and OSE Immunotherapeutics $53.95M. Latest stage: Apollomics Post-IPO Equity, OSE Immunotherapeutics Grant.

Both work in Biotechnology and Pharmaceutical and list cancer treatment, clinical trials and immunotherapy among their focus areas.

Compare Apollomics with someone else

Start typing a company name or domain.

Related Comparisons

Apollomics Alternatives OSE Immunotherapeutics Alternatives All Companies All Signals

Compiled from the BounceWatch company index. We last looked at Apollomics on 12 Sep 2024, and OSE Immunotherapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.